The objective of this study was to assess whether the standard therapy of ready-to-use therapeutic food in the treatment of uncomplicated severe acute malnutrition (SAM) is effective in improving developmental potential and weight gain in children aged under five years. A multicenter pretest-posttest study was conducted among 91 children aged under five with uncomplicated SAM in Pakistan. Study participants completed their eight weeks' therapy of ready-to-use therapeutic food according to the World Health Organization's (WHO) standard guidelines. The study outcome was the proportion of children with improved developmental potential in all domains in comparison with the pretreatment status and children gaining >15% of their baseline weight; mean weight-for-height/length z-score after completing eight weeks' therapy of ready-to-use therapeutic food. The Denver Development Screening Tool II was used for developmental screening. Significant changes ( < 0.05) were observed for developmental status milestones in terms of gross motor, fine motor, and personal/social milestones, as well as language and global development milestones. There was a strong positive correlation (r = 0.961) between initial weight and weight at the last visit ( < 0.001). Ready-to-use therapeutic food is effective in improving development potential as well as promoting weight gain in children aged under five with uncomplicated SAM if provided according to WHO guidelines.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430796 | PMC |
| http://dx.doi.org/10.3390/ijerph18179060 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Computer-assisted medical history taking prior to patient consultation in the outpatient care setting: a prospective pilot project.
BMC Health Serv Res
December 2024
Chair for Artificial Intelligence and Knowledge Systems, University of Würzburg, Würzburg, Germany.
Background: Feeding patients' self-reported medical history into the diagnostic care process may accelerate workflows in clinical routine.
Methods: We prospectively piloted a novel medical history documentation system in a German cardiological outpatient practice and evaluated its feasibility and perceived usefulness. Based on a generic software that allows to record structured information, a customized solution for the cooperating practice was developed and implemented.
Development of a controlled-release mosquito RNAi yeast larvicide suitable for the sustained control of large water storage containers.
Sci Rep
December 2024
Department of Medical and Molecular Genetics, Indiana University School of Medicine, Raclin-Carmichael Hall, 1234 Notre Dame Ave., South Bend, IN, 46617, USA.
Article Synopsis
- Large household water storage containers are key breeding sites for Aedes aegypti mosquitoes, which spread diseases like dengue.
- Concerns over insecticide resistance and safety are challenging effective mosquito control, leading researchers to explore RNAi-based yeast larvicides as a solution.
- A study developed a shelf-stable, controlled-release yeast formulation that shows promise for lasting mosquito control, demonstrating effectiveness in various container sizes and remaining active for up to six months.
Linear Growth During Treatment With a Simplified, Combined Protocol: Secondary Analyses of Severely Wasted Children 6-59 Months in the ComPAS Cluster Randomized Controlled Trial.
Matern Child Nutr
December 2024
International Rescue Committee, New York City, New York, USA.
Article Synopsis
- * A secondary analysis from previous trials found that linear growth and weight gain velocities in children with SAM were similar between the new simplified treatment and the standard treatment, despite using lower RUTF doses.
- * The results suggest that using a reduced RUTF dosage for treating SAM does not negatively impact linear growth or overall growth velocities, indicating that the simplified protocol is an effective option.
Xenogeneic-free culture of human intestinal stem cells on functional polymer-coated substrates for scalable, clinical-grade stem cell therapy.
Nat Commun
December 2024
Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Yuseong-gu, Daejeon, Republic of Korea.
Article Synopsis
- - The study addresses the limitations of using undefined basement membrane extracts like Matrigel for cultivating intestinal stem cells (ISCs) by introducing a new xenogeneic-free culture dish called XF-DISC.
- - XF-DISC significantly increases the growth and maintenance of ISCs, achieving a 24-fold cell number increase within 30 days and sustaining viability over 210 days (30 passages).
- - This method allows for successful transplantation of cultured human ISCs into mouse models with intestinal injuries, fostering tissue regeneration, making it a promising approach for effective ISC therapy in human intestinal diseases.
Patient preferences on pen injectors for assisted reproductive technology: a discrete choice experiment in France.
Expert Opin Drug Deliv
December 2024
Antoine Béclère Hospital, Department of Reproductive Medicine and Fertility Preservation, Clamart, France.
Article Synopsis
- The study aimed to understand patient preferences regarding pen injectors used in Assisted Reproduction Technology (ART) in France, focusing on treatment adherence.
- Using a discrete choice experiment with 155 women averaging 34 years old, researchers evaluated six attributes related to injector pens.
- Results indicated that patients highly valued features like dose confirmation, digital dose counters, multi-use capabilities, and the convenience of ready-to-use pens.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!